XML 70 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jan. 28, 2022
Jan. 29, 2021
Jan. 28, 2022
Jan. 29, 2021
Disaggregation of Revenue [Line Items]        
Net sales $ 7,763 $ 7,775 $ 23,597 $ 21,929
U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 3,939 3,939 12,038 11,344
Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 2,438 2,522 7,517 7,143
Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 1,385 1,314 4,043 3,443
Cardiovascular        
Disaggregation of Revenue [Line Items]        
Net sales 2,745 2,707 8,462 7,865
Cardiovascular | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 1,297 1,272 4,090 3,854
Cardiovascular | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 935 941 2,886 2,739
Cardiovascular | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 513 493 1,486 1,271
Medical Surgical        
Disaggregation of Revenue [Line Items]        
Net sales 2,290 2,313 6,910 6,399
Medical Surgical | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 990 959 2,950 2,677
Medical Surgical | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 812 868 2,521 2,425
Medical Surgical | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 488 486 1,439 1,297
Neuroscience        
Disaggregation of Revenue [Line Items]        
Net sales 2,144 2,126 6,484 5,900
Neuroscience | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 1,397 1,401 4,237 3,934
Neuroscience | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 431 444 1,330 1,246
Neuroscience | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales 316 280 918 720
Diabetes        
Disaggregation of Revenue [Line Items]        
Net sales 584 630 1,741 1,766
Diabetes | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 255 307 760 879
Diabetes | Non-U.S. Developed Markets        
Disaggregation of Revenue [Line Items]        
Net sales 261 268 780 733
Diabetes | Emerging Markets        
Disaggregation of Revenue [Line Items]        
Net sales $ 68 $ 55 $ 201 $ 154